Fig. 2From: Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature reviewHistorical objective response rate (ORR) with chemotherapy in 2L+ mTNBC. Meta-analysis of the seven cohorts from six studies reporting ORR with single-agent chemotherapy in second or later line treatment settingsBack to article page